Publicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (15)

2024

  1. Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia

    Leukemia

2023

  1. High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations

    Microbiology spectrum, Vol. 11, Núm. 4, pp. e0067423

  2. Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma

    Annals of Hematology, Vol. 102, Núm. 2, pp. 429-437

2022

  1. A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results

    Leukemia and Lymphoma, Vol. 63, Núm. 1, pp. 93-100

  2. IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice

    International Journal of Hematology, Vol. 116, Núm. 3, pp. 381-392

2021

  1. Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura

    Journal of Clinical Apheresis, Vol. 36, Núm. 4, pp. 563-573

2019

  1. The poor prognosis of low hypodiploidy in adults with B-cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients

    British Journal of Haematology, Vol. 186, Núm. 2, pp. 263-268

2017

  1. Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphoma

    Cancer Medicine, Vol. 6, Núm. 12, pp. 2766-2774

  2. Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea

    Haematologica, Vol. 102, Núm. 1, pp. 103-109

2016

  1. Spanish consensus guidelines on prophylaxis with bypassing agents in patients with haemophilia and inhibitors

    Thrombosis and Haemostasis, Vol. 115, Núm. 5, pp. 872-895

2012

  1. Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism

    Journal of Thrombosis and Haemostasis, Vol. 10, Núm. 5, pp. 751-759

2010

  1. Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: Results of a Spanish multicenter study

    Transfusion and Apheresis Science, Vol. 43, Núm. 3, pp. 299-303

2009

  1. Efficacy and safety of Liposomal cytarabine in lymphoma Patients with central nervous system involvement from lymphoma

    Cancer, Vol. 115, Núm. 9, pp. 1892-1898

2008

  1. Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study

    Medicina Clinica, Vol. 131, Núm. 11, pp. 401-405

  2. Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in Spain

    Medicina Clinica, Vol. 131, Núm. 12, pp. 441-446